Viatris Share Price Plunges Amid Weak 2021 Financial Guidance

Adjusted EBITDA Expectations Approximately $1bn Lower Than Expected

 
• By Dean Rudge
  
Sea
Viatris is confident that 2021 will be its trough year, though some analysts continue to be skeptical. • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business